Center Of Target Therapy

This study is testing if a medication called semaglutide, given as a weekly injection for three years, can improve liver health in people with fatty liver disease linked to obesity and diabetes. It will involve 70 adults and closely monitor their liver condition, weight, and hear…

This study follows 30 people with a specific type of hepatitis C who have mild to moderate liver scarring. All participants are already receiving a two-drug treatment (ravidasvir + sofosbuvir) as part of their regular care. Researchers will check if the virus is cleared from thei…